← Back
$AXSM All transactions

Axsome Therapeutics, Inc.

A

$ Value

$0

Shares

54,623

Price

$0

Filed

Feb 27

Insider

Name

TABUTEAU HERRIOT

Title

Chief Executive Officer

CIK

0001219927

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2026-02-26

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

54,623

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | 25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in three substantially equal annual installments, such that the RSUs will be fully vested on February 26, 2030. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's 2025 Long-Term Incentive Plan ("2025 Plan")), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the 2025 Plan), or termination due to death or Total and Permanent Disability (as defined in the 2025 Plan)), or (iii) seven (7) years from the date of grant.

Filing Info

Accession No.

0001193125-26-083609

Form Type

4

Issuer CIK

0001579428

TABUTEAU HERRIOT's History

Date Ticker Type Value
2026-04-21 AXSM A $0
2026-02-26 AXSM A $0
2026-02-02 AXSM M $260K
2026-02-02 AXSM $6.0M
2026-02-02 AXSM M $0
2026-01-07 AXSM M $251K
2026-01-07 AXSM $5.3M
2026-01-07 AXSM M $0
2026-01-06 AXSM M $236K
2026-01-06 AXSM $5.1M

Other Insiders at AXSM (90d)

Insider Bought Sold Last
TABUTEAU HERRIOT
Chief Executive Officer
$6.0M 2026-04-21
Coleman Mark $4.0M 2026-02-26
Pizzie Nick
Chief Financial Officer
2026-04-21
Jacobson Mark L.
Chief Operating Officer
$5.7M 2026-04-21
Murdock Hunter R.
General Counsel
2026-04-21
Maizel Ari
Chief Commercial Officer
$1.4M 2026-04-22